Aytu Bioscience (AYTU) could be a solid investment
What’s up with Aytu Bioscience?
Aytu Bioscience (AYTU) opened at $1.50, which means the stock is down 3.20% from yesterday’s closing price of 1.52. Today, the company has a high of $1.55 and a low of $1.45. The company has a market cap of $134.17 million with a 52-week high of $2.99 and a 52-week low of $0.34.
What about the future for Aytu Bioscience?
The high forecast for Aytu Bioscience is $5.00 while the low is $2.50. Stock forecasts are based on human experience: Human traders based on their experience in terms of stock price patterns, volume changes, and market news/rumors regarding a particular stock. Aytu Bioscience has a strong forecast. A strong forecast is a result of strong earning reports as investors are willing to pay a higher share price today because of growth expectations in the future. Based on this information AYTU seems to be a safe buy.
About Aytu Bioscience
Aytu BioScience, Inc. is a specialty pharmaceutical company, which focuses on identifying, acquiring, and commercializing novel products. Its products include Natesto, Tuzistram, ZolpiMist and MiOXSYS. The company was founded on August 9, 2002 and is headquartered in Englewood, CO.